BC
LUNG icon

Birchview Capital’s Pulmonx LUNG Stock Holding History

Birchview Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Sell
200,543
-49,678
-20% -$68.4K 0.12% 65
2026
Q1 		$323K Sell
250,221
-352
-0.1% -$582 0.18% 59
2025
Q4 		$554K Buy
+250,573
New +$471K 0.32% 52
2025
Q2 		– Sell
-51,000
Closed -$343K – 77
2025
Q1 		$343K Hold
51,000
– – 0.3% 39
2024
Q4 		$346K Buy
+51,000
New +$336K 0.28% 44

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Birchview Capital's LUNG Position: Q2 2026 in Review

Birchview Capital reduced its Pulmonx (LUNG) stake by 20% in Q2 2026, selling an estimated $68.4K and leaving 200,543 shares worth $261K. The position accounts for 0.12% of the portfolio, ranked #65.

Birchview Capital first reported a position in LUNG in Q4 2024 and has held it in 5 quarters since. The position peaked at $554K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Birchview Capital held 200,543 shares of Pulmonx worth $261K as of Q2 2026.
  • Birchview Capital sold 49,678 Pulmonx shares in Q2 2026, an estimated $68.4K.
  • Pulmonx made up 0.12% of Birchview Capital's portfolio in Q2 2026, its #65 holding.
  • Birchview Capital first reported a position in Pulmonx in Q4 2024 and has held it in 5 quarters since.
  • Birchview Capital's Pulmonx position peaked at $554K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.